Kenta Biotech AG
  • Home
  • Shop
  • Events
  • Courses
  • Services
  • Pricing
  • Company
    • Blog
    • Success Stories
    • About Us
  • Appointment
  • Contact us
  • 0
  • +1 (718) 513-2983
  • Sign in
  • Contact Us
Kenta Biotech AG
  • 0
    • Home
    • Shop
    • Events
    • Courses
    • Services
    • Pricing
    • Company
      • Blog
      • Success Stories
      • About Us
    • Appointment
    • Contact us
  • +1 (718) 513-2983
  • Sign in
  • Contact Us
  1. Products
  2. E. coli Recombinant
Public Pricelist
Public Pricelist
Sort By: Featured
Featured Newest Arrivals Name (A-Z) Price - Low to High Price - High to Low

E. coli Recombinant

[0468-22060065-1] Epstein-Barr Virus (HHV-4) p23, (E. coli Rec.) - 100ug.
Epstein-Barr Virus (HHV-4) p23, (E. coli Rec.) - 100ug.
451.00 € 451.0 EUR
[0937-TP790050] EGFP Escherichia coli E. coli Rec. Protein-250 µg
EGFP Escherichia coli E. coli Rec. Protein-250 µg
270.00 € 270.0 EUR
[0544-MBS516818-0.25mG.] Derp2 E. coli Rec. protein :: Der p 2 E. coli Rec. Protein
Derp2 E. coli Rec. protein :: Der p 2 E. coli Rec. Protein
865.00 € 865.0 EUR
[0544-MBS143474-01] Dengue Virus NS1 Type 2 , E. coli Rec. Protein - 0.1 mG.
Dengue Virus NS1 Type 2 , E. coli Rec. Protein - 0.1 mG.
421.00 € 421.0 EUR
[0544-MBS143970-0.005mG.] DCTD E. coli Rec. protein :: dCMP Deaminase E. coli Rec. Protein 0.005mG.
DCTD E. coli Rec. protein :: dCMP Deaminase E. coli Rec. Protein 0.005mG.
506.00 € 506.0 EUR
[0002-0801700] Cryptosporidium parvum-S. cerevisiae E. coli Rec., titered - 1 mL
Cryptosporidium parvum-S. cerevisiae E. coli Rec., titered - 1 mL
790.00 € 790.0 EUR
[0544-MBS2030557-0.01mG.] Mouse Low Density Lipoprotein Receptor Related Protein 1 (LRP1) E. coli Rec. Protein - 0.01 mG.
Mouse Low Density Lipoprotein Receptor Related Protein 1 (LRP1) E. coli Rec. Protein - 0.01 mG.
367.00 € 367.0 EUR
[0708-PABC-104-4X1mG.] Mouse Anti-Phosphocholine E. coli Rec. Antibody (clone MCPC603)-Regular Batch (No Endotoxin Removal), SDS-PAGE>95%, Chimeric IgA/IgG, kappa, 4X1 mG.
Mouse Anti-Phosphocholine E. coli Rec. Antibody (clone MCPC603)-Regular Batch (No Endotoxin Removal), SDS-PAGE>95%, Chimeric IgA/IgG, kappa, 4X1 mG.
9,750.00 € 9750.0 EUR
[0708-PABC-104-1mG.] Mouse Anti-Phosphocholine E. coli Rec. Antibody (clone MCPC603)-Regular Batch (No Endotoxin Removal), SDS-PAGE>95%, 1mG.
Mouse Anti-Phosphocholine E. coli Rec. Antibody (clone MCPC603)-Regular Batch (No Endotoxin Removal), SDS-PAGE>95%, 1mG.
5,530.00 € 5530.0 EUR
[0708-FAMAB-0260CQ-1 mG.] Mouse Anti-Phosphocholine E. coli Rec. Antibody (clone 198.3D3)-Regular Batch (No Endotoxin Removal), SDS-PAGE>95%, 3X1 mG.
Mouse Anti-Phosphocholine E. coli Rec. Antibody (clone 198.3D3)-Regular Batch (No Endotoxin Removal), SDS-PAGE>95%, 3X1 mG.
3,059.00 € 3059.0 EUR
[0708-MOB-1610z] Mouse Anti-PLG E. coli Rec. Antibody (clone 27C1) -150 uL
Mouse Anti-PLG E. coli Rec. Antibody (clone 27C1) -150 uL
1,420.00 € 1420.0 EUR
[0708-MOR-0019-FY] Mouse Anti-MRC1 E. coli Rec. Antibody [Clone: 15-2] - 500 ug.
Mouse Anti-MRC1 E. coli Rec. Antibody [Clone: 15-2] - 500 ug.
4,350.00 € 4350.0 EUR
[0708-CBMAB-I0044-YY-5X0.2 mG.] Mouse Anti-IgG Fd Ab E. coli Rec. Antibody (HP6045), 1 mG.(5X0.2mG.)
Mouse Anti-IgG Fd Ab E. coli Rec. Antibody (HP6045), 1 mG.(5X0.2mG.)
4,620.00 € 4620.0 EUR
[0708-CBMAB-I0044-YY-0.2 mG.] Mouse Anti-IgG Fd Ab E. coli Rec. Antibody (HP6045), 0.2 mG.
Mouse Anti-IgG Fd Ab E. coli Rec. Antibody (HP6045), 0.2 mG.
1,785.00 € 1785.0 EUR
[0708-ZG-471C] Mouse Anti-IgE E. coli Rec. Antibody (clone 1E7H11) - 100 μg
Mouse Anti-IgE E. coli Rec. Antibody (clone 1E7H11) - 100 μg
1,683.00 € 1683.0 EUR
[0708-HPAB-AP094-YC] Mouse Anti-GPR87 E. coli Rec. Antibody - SDS-PAGE>95%, Regular batch (without endotoxin removal)
Mouse Anti-GPR87 E. coli Rec. Antibody - SDS-PAGE>95%, Regular batch (without endotoxin removal)
5,999.00 € 5999.0 EUR
[0708-HPAB-0561-CN] Mouse Anti-GPC3 E. coli Rec. Antibody (clone GC33), 0.5 mG.
Mouse Anti-GPC3 E. coli Rec. Antibody (clone GC33), 0.5 mG.
4,350.00 € 4350.0 EUR
[0708-HPAB-AP605-YC-1mG.] Mouse Anti-Citrullinated epitope E. coli Rec. Antibody (clone 12G1) - 1 mG.
Mouse Anti-Citrullinated epitope E. coli Rec. Antibody (clone 12G1) - 1 mG.
5,259.00 € 5259.0 EUR
[0015-JEV14-M] Monoclonal Anti-Rec. Japanese Encephalitis Virus (JEV) envelop protein E (JEV-EP), Antiserum Unpurified - 100ul
Monoclonal Anti-Rec. Japanese Encephalitis Virus (JEV) envelop protein E (JEV-EP), Antiserum Unpurified - 100ul
585.00 € 585.0 EUR
[0015-JEV13-M] Monoclonal Anti-Rec. Japanese Encephalitis Virus (JEV) PreM protein IgG 100ul
Monoclonal Anti-Rec. Japanese Encephalitis Virus (JEV) PreM protein IgG 100ul
630.00 € 630.0 EUR
  • 3
  • 4
  • 5
  • 6
  • 7

Clear Filters



Respiratory syncytial virus (RSV) infections are the most common cause of hospitalization in early childhood, accounting for 57 000 to 120 000 hospitalizations each year in the United States. RSV is causing annual epidemics of bronchiolitis and pneumonia worldwide. In most cases the infection with RSV heals without sequelae, yet RSV infection can cause lung function deterioration and in some circumstances, years of recurrent wheezing or asthma may ensue. Overall RSV accounts for an estimated2% of the hospitalization rate among infants less than 1 year of age. This rate increases 4–5-fold among high-risk patients such as premature infants and those with chronic lung disease or complicated congenital heart disease.


Currently there is only one possibility to prevent infections of at-risk patients with RSV, namely immuno-prophylaxis with palivizumab/Synagis, marketed by MedImmune. However, the response to palivizumab is variable among individuals, and sometimes palivizumab fails to prevent RSV infections effectively.


Due to the lack of better antibodies, lack of effective anti-viral treatment and lack of an effective preventive vaccine for RSV, there is a substantial medical need for more efficacious prophylactic immunizations, e.g. by antibody.


Kenta Biotech had developed a fully human monoclonal antibody (KBRV201) derived from B-cells of a human donor. KBRV201 is of the human IgG1 isotype with specificity and very high affinity for the F-protein of human respiratory syncytial virus (hRSV). KBRV201 has been tested for recognition and neutralization of hRSV strains -A, -B and –Long, and KBRV201 could neutralize in vitro all strains tested with higher efficacy than other anti-F-protein mAb.




KBRV201 successfully recognizes 22 clinical isolates from children infected with RSV, including one isolate with a mutated F-protein. Overall KBRV201 has demonstrated superiority in every experiment performed, and KBRV201 is currently undergoing extensive testing in animal models.

14009 NW Harbor Ln, Portland, OR 97229, USA.


Follow us
Copyright © 2025 Kenta Biotech AG
English (UK) English (US)